We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novartis Dismisses Some Exelon Patent Claims

Law360 (April 23, 2007, 12:00 AM EDT) -- A federal judge on Thursday approved Novartis Pharmaceuticals Corp.’s requests to dismiss claims for infringement of one patent involved in a multidistrict dispute over Exelon, the Swiss drug maker’s Alzheimer’s treatment....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.